OBJECTIVE: In addition to the increasingly recognized role of physical exercise in maintaining cognition, exercise may influence Alzheimer's disease (AD) pathology, as transgenic mouse studies show lowered levels of AD pathology in exercise groups. The objective of this study was to elucidate the association between exercise and AD pathology in humans using Pittsburgh compound-B (PIB), amyloid-beta (Abeta)(42), tau, and phosphorylated tau (ptau)(181) biomarkers. METHODS: Sixty-nine older adults (17 males, 52 females) aged 55 to 88 years, were recruited and confirmed to be cognitively normal. A questionnaire on physical exercise levels over the past decade was administered to all. Cerebrospinal fluid samples were collected from 56 participants, and amyloid imaging with PIB was performed on 54 participants. RESULTS: Participants were classified based on biomarker levels. Those with elevated PIB (p = 0.030), tau (p = 0.040), and ptau(181) (p = 0.044) had significantly lower exercise, with a nonsignificant trend for lower Abeta(42) (p = 0.135) to be associated with less exercise. Results were similar for PIB after controlling for covariates; tau (p = 0.115) and ptau(181) (p = 0.123) differences were reduced to nonsignificant trends. Additional analyses also demonstrated that active individuals who met the exercise guidelines set by the American Heart Association had significantly lower PIB binding and higher Abeta(42) levels with and without controlling for covariates (PIB: p = 0.006 and p = 0.001; Abeta(42): p = 0.042 and p = 0.046). Last, the associations between exercise engagement and PIB levels were more prominent in APOE epsilon 4 noncarriers. INTERPRETATION: Collectively, these results are supportive of an association between exercise engagement and AD biomarkers in cognitively normal older adults.
OBJECTIVE: In addition to the increasingly recognized role of physical exercise in maintaining cognition, exercise may influence Alzheimer's disease (AD) pathology, as transgenicmouse studies show lowered levels of AD pathology in exercise groups. The objective of this study was to elucidate the association between exercise and AD pathology in humans using Pittsburgh compound-B (PIB), amyloid-beta (Abeta)(42), tau, and phosphorylated tau (ptau)(181) biomarkers. METHODS: Sixty-nine older adults (17 males, 52 females) aged 55 to 88 years, were recruited and confirmed to be cognitively normal. A questionnaire on physical exercise levels over the past decade was administered to all. Cerebrospinal fluid samples were collected from 56 participants, and amyloid imaging with PIB was performed on 54 participants. RESULTS:Participants were classified based on biomarker levels. Those with elevated PIB (p = 0.030), tau (p = 0.040), and ptau(181) (p = 0.044) had significantly lower exercise, with a nonsignificant trend for lower Abeta(42) (p = 0.135) to be associated with less exercise. Results were similar for PIB after controlling for covariates; tau (p = 0.115) and ptau(181) (p = 0.123) differences were reduced to nonsignificant trends. Additional analyses also demonstrated that active individuals who met the exercise guidelines set by the American Heart Association had significantly lower PIB binding and higher Abeta(42) levels with and without controlling for covariates (PIB: p = 0.006 and p = 0.001; Abeta(42): p = 0.042 and p = 0.046). Last, the associations between exercise engagement and PIB levels were more prominent in APOE epsilon 4 noncarriers. INTERPRETATION: Collectively, these results are supportive of an association between exercise engagement and AD biomarkers in cognitively normal older adults.
Authors: Anne M Fagan; Denise Head; Aarti R Shah; Daniel Marcus; Mark Mintun; John C Morris; David M Holtzman Journal: Ann Neurol Date: 2009-02 Impact factor: 10.422
Authors: Sean P Deeny; David Poeppel; Jo B Zimmerman; Stephen M Roth; Josef Brandauer; Sarah Witkowski; Joseph W Hearn; Andrew T Ludlow; José L Contreras-Vidal; Jason Brandt; Bradley D Hatfield Journal: Biol Psychol Date: 2008-03-02 Impact factor: 3.251
Authors: David A Costa; Jennifer R Cracchiolo; Adam D Bachstetter; Tiffany F Hughes; Kelly R Bales; Steven M Paul; Ronald F Mervis; Gary W Arendash; Huntington Potter Journal: Neurobiol Aging Date: 2006-05-26 Impact factor: 4.673
Authors: Annika Olsson; Hugo Vanderstichele; Niels Andreasen; Geert De Meyer; Anders Wallin; Björn Holmberg; Lars Rosengren; Eugeen Vanmechelen; Kaj Blennow Journal: Clin Chem Date: 2004-11-24 Impact factor: 8.327
Authors: Gary W Arendash; Marcos F Garcia; David A Costa; Jennifer R Cracchiolo; Inge M Wefes; H Potter Journal: Neuroreport Date: 2004-08-06 Impact factor: 1.837
Authors: Gary W Small; Prabha Siddarth; Alison C Burggren; Vladimir Kepe; Linda M Ercoli; Karen J Miller; Helen Lavretsky; Paul M Thompson; Greg M Cole; S C Huang; Michael E Phelps; Susan Y Bookheimer; Jorge R Barrio Journal: Arch Gen Psychiatry Date: 2009-01
Authors: Harald Hampel; Katharina Bürger; Stefan J Teipel; Arun L W Bokde; Henrik Zetterberg; Kaj Blennow Journal: Alzheimers Dement Date: 2007-12-21 Impact factor: 21.566
Authors: Susan M Landau; Shawn M Marks; Elizabeth C Mormino; Gil D Rabinovici; Hwamee Oh; James P O'Neil; Robert S Wilson; William J Jagust Journal: Arch Neurol Date: 2012-05
Authors: C A Raji; H Eyre; S H Wei; D E Bredesen; S Moylan; M Law; G Small; P M Thompson; R M Friedlander; D H Silverman; B T Baune; T A Hoang; N Salamon; A W Toga; M W Vernooij Journal: AJNR Am J Neuroradiol Date: 2015-06-04 Impact factor: 3.825
Authors: Christopher M Gidicsin; Jacqueline E Maye; Joseph J Locascio; Lesley C Pepin; Marlie Philiossaint; J Alex Becker; Alayna P Younger; Maria Dekhtyar; Aaron P Schultz; Rebecca E Amariglio; Gad A Marshall; Dorene M Rentz; Trey Hedden; Reisa A Sperling; Keith A Johnson Journal: Neurology Date: 2015-06-10 Impact factor: 9.910
Authors: Stephan Müller; Oliver Preische; Hamid R Sohrabi; Susanne Gräber; Mathias Jucker; John M Ringman; Ralph N Martins; Eric McDade; Peter R Schofield; Bernardino Ghetti; Martin Rossor; Nick N Fox; Neill R Graff-Radford; Johannes Levin; Adrian Danek; Jonathan Vöglein; Stephen Salloway; Chengjie Xiong; Tammie Benzinger; Virginia Buckles; Colin L Masters; Reisa Sperling; Randall J Bateman; John C Morris; Christoph Laske Journal: Alzheimers Dement Date: 2018-09-25 Impact factor: 21.566
Authors: Belinda M Brown; Hamid R Sohrabi; Kevin Taddei; Samantha L Gardener; Stephanie R Rainey-Smith; Jeremiah J Peiffer; Chengjie Xiong; Anne M Fagan; Tammie Benzinger; Virginia Buckles; Kirk I Erickson; Roger Clarnette; Tejal Shah; Colin L Masters; Michael Weiner; Nigel Cairns; Martin Rossor; Neill R Graff-Radford; Stephen Salloway; Jonathan Vöglein; Christoph Laske; James Noble; Peter R Schofield; Randall J Bateman; John C Morris; Ralph N Martins Journal: Alzheimers Dement Date: 2017-05-11 Impact factor: 21.566